It's All About-Accredited Charity-Winston-Salem-Curing Type 1 Diabetes
JDRF is the leading global organization funding type 1 diabetes (T1D) research. Millions of people around the world live with type 1 diabetes (T1D), a life-threatening autoimmune disease that strikes both children and adults. There is no way to prevent it, and at present, no cure. JDRF works every day to change this by amassing grassroots support, deep scientific knowledge and strong industry and academic partnerships to fund research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until they achieve a world without T1D.
JDRF is a major charitable 501 organization dedicated to funding type 1 diabetes research. JDRF’s stated vision is “a world without type 1 diabetes.” The city of Winston-Salem is a product of the merging of the two neighboring towns of Winston and Salem in 1913.
Winston-Salem is in the northwest Piedmont area of North Carolina, situated 65 miles (105 km) northwest of the geographic center of the state. According to the United States Census Bureau, the city has a total area of 133.7 square miles (346.3 km2), of which 132.4 square miles (343.0 km2) is land and 1.2 square miles (3.2 km2), or 0.93%, is water.
Less than 30 miles (48 km) north of Winston-Salem are the remains of the ancient Sauratown Mountains, named for the Saura people who lived in much of the Piedmont area, including where is now Winston-Salem.
The nearest major cities are Greensboro, 30 miles (48 km) to the east, and High Point 20 miles (32 km) to the southeast. While insulin injections or infusion allow a person with T1D to stay alive, they do not cure the disease, nor do they necessarily prevent the possibility of the disease’s serious effects, which may include: kidney failure, blindness, nerve damage, amputations, heart attack, stroke, and pregnancy complications. Although type 1 diabetes is a serious and difficult disease, treatment options are improving all the time, and people with T1D can lead full and active lives. JDRF is driving research to improve the technology people with T1D use to monitor blood sugar levels and deliver the proper doses of insulin, as well as research that will ultimately deliver a cure. Diagnosing Diabetes:
– A1C Test – measures your average blood glucose for the past 2 to 3 months. If the score is equal to or greater than 6.5%, diabetes is present. The primary advantage of being diagnosed using this test is that there is no requirement to fast or drink anything. A score of less than 5.7% would be normal and no presence of diabetes. A score between 5.7% and 6.4% is a prediabetes indication. See full list of Media Credits http://broadcaster.beazil.net/public/credits/youtube/videos/41735 Health Care & Social Assistance sector comprises firms providing health care and social assistance for individuals. The sector includes both health care and social assistance because it is sometimes difficult to distinguish between the boundaries of these two activities. The industries in this sector are arranged on a continuum starting with providing medical care exclusively, continuing with those providing health care and social assistance and finally finishing with only social assistance. The services provided in this sector are delivered by trained health practitioners and social workers with requisite experience. JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
A number of key issues arise from the mentioned above. For instance:
Diabetes and Pregnancy,preprandial blood glucose,insulin resistance,Prevention of diabetes complications,support our research,gestational diabetes mellitus,cholesterol levels,prone to ketoacidosis,diabetes diagnosis,ADVANCE Trial,Special Diabetes Program,T1D burden,Cackalacky,Insulin Therapy,Rapid Acting Insulin,Type 1,rebound hyperglycemia,Oral Glucose Tolerance Test,Research Funding,Scientific,Type 1 Diabetes,diabetes related complications,reality of T1D,DILfrequency study,impaired glucose tolerance,Sodium–glucose cotransporter 2 inhibitors,CONCEPTT,negative diabetes associated autoantibodies,PIs,The Rip Van Winkle State,funding research,US-NC,life-changing breakthroughs,noninsulin monotherapy,research,diabetes prevention program,gestational diabetes,50/50 insulin,charity,glyburide,IGT,unit of insulin,Bolus insulin,A1C,Diabetes.